In An Emergency, Value Of Drug-Eluting Stents Still Questionable, Docs Say
This article was originally published in The Gray Sheet
Executive Summary
More data is needed before drug-eluting stents should be considered for routine use as part of emergency treatment for a heart attack, according to an editorial in the Sept. 14 New England Journal of Medicine
You may also be interested in...
Drug-Eluting Stents Perform Well In An Emergency, NEJM Data Shows
Drug-eluting stents reduce the rates of two-year mortality, heart attack recurrence and repeat revascularization compared with bare-metal stents in acute myocardial infarction patients, according to the results of a large observational study reported Sept. 25
Drug-Eluting Stents Perform Well In An Emergency, NEJM Data Shows
Drug-eluting stents reduce the rates of two-year mortality, heart attack recurrence and repeat revascularization compared with bare-metal stents in acute myocardial infarction patients, according to the results of a large observational study reported Sept. 25
Drug-eluting Stents Perform Well In An Emergency, NEJM Study Shows
AMI long-term outcomes were better than with bare-metal option in the Mass. study, but a national registry would provide long-term safety data for more patient types.